Campaign reflects on lessons learnt over the course of the COVID-19 pandemic
Campaign reflects on lessons learnt over the course of the COVID-19 pandemic
New report finds 60 cancer cases per day could be avoided in less wealthy areas
New therapy granted a Promising Innovative Medicine designation by UK agency
First subject dosed with new drug candidate from strategic collaboration
Treatment becomes first and only biologic for HES in the US
Treatment is being developed by Australian biotech Ena Respiratory
First phase will see company deploy 300 PCR instruments to the UK
Insights from project could potentially improve precision medicine use for paediatric AML
Drug is being investigated in up to 800 hospitalised patients nationwide
Treatment is indicated for use in adults with moderate-to-severe active rheumatoid arthritis
Pharma industry bodies call for medicine supply to be safeguarded in upcoming talks
Zercepac will be available for HER2-positive breast and gastric cancers
ICR and Cancer Research UK spinout closes Series B financing
Survey commissioned by Johnson & Johnson for World Pharmacists Day
Trial is being conducted in partnership with UK government’s Vaccines Taskforce